Veterinary Diagnostics Market Size & Share, by Product (Consumables and Instruments); Technology (Hematology, Immunodiagnostics, Molecular Diagnostics, Clinical biochemistry); Animal Type - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 6378
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Veterinary Diagnostics Market size was over USD 8.6 billion in 2023 and is anticipated to exceed USD 15.4 billion by the end of 2036, growing at over 5% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of veterinary diagnostics is estimated at 9.03 billion.

The steep growth trajectory is modulated by the rising need for pet ownership and humanization, rapid advancements in diagnostics technology enabling faster and more accurate test results, expansion of veterinary healthcare infrastructure, increased animal expenditures, and a growing number of veterinary practitioners. Many key players are focused on offering innovative diagnostic products and kits for companion animals as well as livestock. In November 2023, IDEXX Laboratories Inc. announced the launch of a comprehensive test named SNAP Leish 4Dx which detects vector-borne diseases. This move helped the company boost its credibility and widen its portfolio.

Progress in diagnostics technologies such as molecular diagnostics, imaging modalities, and point-of-care (PoC) testing has greatly increased the capacity to diagnose complex illnesses in animals. For instance, in April 2023, BioCheck announced the launch of a real-time biosecurity diagnostic tool, VetAssure for pigs and poultry that uses bioluminescence technology to identify and measure ATP.


Veterinary Diagnostics Market Overview
Get more information on this report: Request Free Sample PDF

Veterinary Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers:

  • Increasing pet ownership: Pet ownership is becoming more prominent as people seek companionship and demonstrate responsible pet care. The surge in pet ownership amongst people in urban areas is likely to escalate the sales of veterinary diagnostics. Owners are now seeking advanced diagnostics tests and treatments, to ensure the optimal health of their pets. This has resulted in increasing demand for preventive care, advanced medications, and point of care.  

    Overall, the shift towards more personalized pet care has created a lucrative market for veterinary diagnostics, with owners willing to invest in their pet’s health and well-being, thus, fueling the investments in veterinary healthcare infrastructure. A report by the European Pet Food Industry (FEDIAF) 2022 confirms a healthy growth of pet ownership with 166 million European households (50%) owning one or more of the region’s 352 million pets.
  • Rising concerns about animal health: The rising concerns about animal health and welfare is a significant driver for the veterinary diagnostics market. As public awareness of animal welfare issues grows, so does the demand for diagnostic tests to monitor health. Advancements in animal health research and development, coupled with government initiatives and regulations supporting animal health and welfare, are fueling overall market growth.

    Social media plays a crucial role in raising consumer awareness and boosting demand for products from companies that prioritize animal well-being.As a result, animal health and welfare have become increasingly important in the market, leading to a surge in demand for diagnostics tests and services that support animal well-being. This trend is expected to continue driving growth and innovation in the market.

    For instance, the American Animal Hospital Association (AAHA) has designated September as National Pet Health Awareness Month to raise awareness regarding the significance of preventive care, diagnostics testing, and regular veterinary check-ups for pets.
  • Rapid advancements in diagnostic technology: New cutting-edge innovations and technological advancements in PCR and NGS catalyze the expansion of veterinary diagnostics. Another example is mass spectrometry and imaging tools that facilitate the visualization of health issues more precisely. Artificial intelligence systems and miniaturized biosensors also aid in diagnosis, making it more streamlined for vets to treat animals leading to a systematic and optimized approach for animal wellness and care.

Challenges:

  • High costs of veterinary diagnostics: Continuous research and development require substantial investment inclusive of costs of equipment and instrumentation such as imaging technologies and PCR machines. The cost of reagents and consumables, laboratory setups and maintenance, and regulatory compliance also add to the financial burden. Furthermore, consulting with veterinarians and specialists, and animal handling can be costly, particularly for large or exotic animals. These costs can hinder the adoption of diagnostics testing, especially for economically weaker owners such as farmers in resource-constrained settings.
  • Low awareness about veterinary diagnostics in many parts of the globe: Limited awareness is a significant challenge in the veterinary diagnostics market where the lack of optimal knowledge can hinder the understanding of the adoption of diagnostic tests. Animal owners, veterinarians, and farmers in remote areas may be unaware of the availability or importance of these tests, leading to underutilization and delayed diagnosis.

Veterinary Diagnostics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

5%

Base Year Market Size (2023)

USD 8.6 billion

Forecast Year Market Size (2036)

USD 15.4 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Veterinary Diagnostics Segmentation

Product (Consumables and Instruments)

The consumable segment in the veterinary diagnostics market accounted for a significant share in 2023 and is expected to grow at a healthy pace owing to increasing demand for diagnostics tests, consistent utilization of reagents and kits in veterinary clinics and laboratories, and continuous need for advanced technology to detect emerging diseases. Reagents, kits, and assays are some the commonly used consumables in veterinary diagnostics for varied infectious, genetic, allergy, and toxicology testing.

Technology (Hematology, Immunodiagnostics, Molecular Diagnostics, and Clinical biochemistry and others)

The molecular diagnostics segment is expected to account for a 33.2% share of the veterinary diagnostics market during the forecast period due to its high sensitivity, rapid results, and accurate outcomes. This segment has revolutionized the approach to diagnosing infectious diseases, genetic disorders, and serious health issues in animals by offering efficient methods replacing traditional methods such as PCR, sequencing, and microarrays. These modern and advanced technical methods have become a benchmark in improvising timely and effective diagnosis of animal diseases.

Its ability to detect numerous targets simultaneously and provide timely results has made it an indispensable tool for researchers, veterinarians, and other animal health professionals. Moreover, the portability and easy-to-use features of such molecular diagnostics devices have expanded their reach to point-of-care settings, enabling on-site testing, and making decisions on time the driving forces behind the significant segment growth.

Animal type (Companion, and Livestock)

The companion animal segment is expected to register the fastest growth between 2024 and 2036, owing to increasing pet ownership, and rising concerns about animal health. The increasing adoption of dogs, cats, and horses has resulted in growing demand for premium quality animal well-being products, including diagnostics and devices. Additionally, the growing trend of pet owners seeking human-level healthcare for their pets has led an increase in demand for specialized and sophisticated diagnostics tests and healthcare products. As a result, companies are striving to develop innovative and cost-effective diagnostics solutions for optimal outcomes of companion animal diseases.

Our in-depth analysis of the global market includes the following segments:

Product

  • Consumables
  • Instruments

Technology

 

  • Hematology
  • Immunodiagnostics
  • Molecular Diagnostics
  • Clinical biochemistry
  •  Others

Animal Type

  • Companion
  • Livestock

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Veterinary Diagnostics Industry - Regional Synopsis

North America Market Analysis

North America veterinary diagnostics market is expected to account for 62.2% of the revenue share during the forecast period. This growth can be attributed to increasing pet ownership across the region, growing concerns about animal health and welfare, and presence of advanced veterinary healthcare infrastructure.  Key players in the market such as Zoetis Services LLC, and IDEXX Laboratories Inc., are leading the market by offering advanced diagnostics solutions for companion and livestock.

The U.S. emerged as the dominant country in North America market in 2023 owing to rising prevalence of zoonotic diseases, coupled with advanced diagnostic tools and services. The U.S. boasts one of the largest companion animal populations in the world with millions of pets such as dogs, cats, and other pets. The U.S. has robust a network of veterinary clinics, hospitals, and healthcare facilities that provide advanced diagnostics services fueling the demand for increased veterinary diagnostics tests.

Asia Pacific Market Analysis

Asia Pacific veterinary diagnostics market is expected to expand at a rapid CAGR over the forecast period. This growth can be attributed to increasing pet ownership and livestock breeding, high adoption of advanced diagnostic tools, and ongoing efforts to develop advanced diagnostics tests.

China market is expected to witness robust growth owing to high prevalence of zoonotic diseases, increasing investments in developing advanced diagnostic tools, and growing awareness about animal health and early disease diagnosis. For instance, in May 2021, Boehringer Ingelheim announced approval for its GastroGard drug by the Ministry of Agriculture and Rural Affairs of China and became the first company with an equine business in China.

Research Nester
Veterinary Diagnostics Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Veterinary Diagnostics Landscape

    The veterinary diagnostics market is highly competitive and rapidly evolving driven by increasing demand for advanced diagnostics solutions to improve animal health and well-being, and reliable high-quality food products for animals. As the global population of livestock and companion animals continue to grow, the need for accurate and reliable techniques has gained significance leading to continuous innovation and investment in this field. This market is characterized by the presence of several prominent players such as:

    • Zoetis Services LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Virbac Corporation
    • Zomedica Corp
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Thermo Fisher Scientific Inc
    • BIOCHECK BV
    • Bio-Rad Inc.
    • IDVet
    • Randox Laboratories Ltd.
    • Neogen Corporation
    • Heska Corporation
    • BioMerieux SA

In the News

  • In January 2024, Zoetis Inc, a global leader in animal health announced the expansion of its multiapplication diagnostic platform, Vetscan Imagyst with the addition of AI Urine Sediment analysis.
  • In March 2022, Companion Animal Health promulgated a strategic agreement with HT Biolmaging to co-brand and exclusively sell the HTVet product in US and Canada.

Author Credits:  Radhika Pawar


  • Report ID: 6378
  • Published Date: Sep 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The veterinary diagnostics market size was USD 8.6 billion in 2023.

The global veterinary diagnostics market size was US 8.6 billion in 2023 and is anticipated to reach USD 15.4 billion by the end of 2036, expanding at a CAGR of 5% over the forecast period, i.e., 2024-2036.

Zoetis Services LLC, Virbac Corporation, Zomedica Corp, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Thermo Fisher Scientific Inc, IDEXX Laboratories Inc., Heska Corporation are some prominent companies.

Consumable segment is anticipated to hold a largest share in forecast period of 2024-2036.

North America is projected to offer lucrative prospects in the veterinary diagnostics market in 2024.
Veterinary Diagnostics Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample